Oncology News

Colorectal cancer incidence climbed 500% from 1999 to 2020 among children aged 10 to 14 years and 333% among adolescents aged 15 to 19 years, according to research presented at the Digestive Disease Week media briefing.

A clinical trial at Keck Medicine of USC will investigate a new surgical approach to treating patients with locally advanced pancreatic cancer.

Oral samples taken from patients with gastric cancer and premalignant gastric conditions exhibited “stark differences” in bacterial composition compared with controls, suggesting that oral bacteria could serve as a biomarker.

New testing options for colorectal cancer will likely expand access to screening, but they are not as reliable as a colonoscopy, according to experts.

The FDA has approved Geneoscopy Inc.’s ColoSense multitarget stool RNA test for adults aged 45 years or older at average-risk for developing colorectal cancer, according to a company press release.

The 10-year interval between screening colonoscopies “could potentially be extended” to 15 years among patients without a family history of colorectal cancer and negative findings for CRC at the first colonoscopy, researchers reported.

A regimen of pembrolizumab plus trastuzumab and chemotherapy extended OS for individuals with HER2-positive locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

The FDA has approved trastuzumab-strf as a biosimilar to trastuzumab for the treatment of certain patients with HER2-overexpressing malignancies, according to a press release from the agent’s manufacturer.

Hepatocellular carcinoma screening in at-risk patients was linked to reduced mortality after accounting for lead-time and length-time biases, as well as improved early tumor detection and treatment, according to data in JAMA Network Open.

In a Healio video exclusive, Shria Kumar, MD, MSCE, discusses how community-based eradication of Helicobacter pylori infection may reduce the risk for gastric cancer in historically underrepresented communities and other vulnerable groups.